Body size, physical activity, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk

Carcinogenesis

Volumn 36, Issue 9, 2015, Pages 971-981

  Simons, C C J M ^a   Schouten, L J ^a   Godschalk, R ^b   van Engeland, M ^a   van den Brandt, P A ^a   van Schooten, F J ^a   Weijenberg, M P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SOMATOMEDIN C; IGF1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; BODY HEIGHT; BODY MASS; BODY SIZE; CANCER LOCALIZATION; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUM SCORE; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RECTUM CANCER; SCORING SYSTEM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; COLORECTAL NEOPLASMS; DIET; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOTOR ACTIVITY; NETHERLANDS; PHYSIOLOGY; QUESTIONNAIRE; RISK FACTOR;

AGED; BODY MASS INDEX; BODY SIZE; COHORT STUDIES; COLORECTAL NEOPLASMS; DIET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MOTOR ACTIVITY; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84940663769     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv077     Document Type: Article

References (60)

1. Colorectal cancer | Continuous Update Project | WCRF. http://www.wcrf.org/cancer_research/cup/key_findings/colorectal_cancer.php. (10 May 2013, date last accessed).
2. Baxter, R.C. (2014) IGF binding proteins in cancer: mechanistic and clinical insights. Nat. Rev. Cancer, 14, 329-341.
3. Kaaks, R. et al. (2001) Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc. Nutr. Soc., 60, 91-106.
4. Landi, S. et al. (2003) Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res., 63, 3560-3566.
5. Slattery, M.L. et al. (2004) Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 13, 1206-1214.
6. Jiang, J. et al. (2005) Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population. Cancer Sci., 96, 507-512.
7. Morimoto, L.M. et al. (2005) Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 1204-1211.
8. Wong, H.L. et al. (2005) A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore chinese. Cancer Epidemiol. Biomarkers Prev., 14, 144-151.
9. Koh, W.P. et al. (2006) Peroxisome proliferator-activated receptor (PPAR) gamma gene polymorphisms and colorectal cancer risk among Chinese in Singapore. Carcinogenesis, 27, 1797-1802.
10. Theodoropoulos, G. et al. (2006) Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J. Gastroenterol., 12, 5037-5043.
11. Pechlivanis, S. et al. (2007) Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer. Cancer Detect. Prev., 31, 408-416.
12. Kaklamani, V.G. et al. (2008) Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA, 300, 1523-1531.
13. Küry, S. et al. (2008) Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer, 8, 326.
14. Wong, H.L. et al. (2008) Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach. Gut, 57, 1090-1096.
15. Feik, E. et al. (2010) Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk. Cancer Causes Control, 21, 91-97.
16. Tsilidis, K.K. et al. (2009) Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control, 20, 1739-1751.
17. Xiang, H. et al. (2009) Association between two functional polymorphisms of insulin-like growth factor binding protein 3 and colorectal cancer risk in a Chinese population. J. Toxicol. Environ. Health. A, 72, 706-711.
18. Gao, C.M. et al. (2010) Relationship between growth hormone 1 genetic polymorphism and susceptibility to colorectal cancer. J. Hum. Genet., 55, 163-166.
19. Xu, W. et al. (2010) PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32, 138 subjects. Oncol. Rep., 24, 579-585.
20. He, B. et al. (2011) Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med. Genet., 12, 94.
21. Keku, T.O. et al. (2012) Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Cancer Causes Control, 23, 1127-1138.
22. Samowitz, W.S. et al. (2006) Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer. Mutat. Res., 595, 117-124.
23. Slattery, M.L. et al. (2005) Energy balance, insulin-related genes and risk of colon and rectal cancer. Int. J. Cancer, 115, 148-154.
24. Slattery, M.L. et al. (2009) Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat. Res., 660, 12-21.
25. Bull, A.W. (2003) The role of peroxisome proliferator-activated receptor gamma in colon cancer and inflammatory bowel disease. Arch. Pathol. Lab. Med., 127, 1121-1123.
26. Komninou, D. et al. (2003) Insulin resistance and its contribution to colon carcinogenesis. Exp. Biol. Med. (Maywood), 228, 396-405.
27. Pais, R. et al. (2009) Metabolic syndrome and risk of subsequent colorectal cancer. World J. Gastroenterol., 15, 5141-5148.
28. Deng, L. et al. (2012) Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig. Dis. Sci., 57, 1576-1585.
29. Khoury-Shakour, S. et al. (2008) Recreational physical activity modifies the association between a common GH1 polymorphism and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 17, 3314-3318.
30. Liu, L. et al. (2011) Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer. PLoS One, 6, e27301.
31. Karimi, K. et al. (2013) Is there an association between variants in candidate insulin pathway genes IGF-I, IGFBP-3, INSR, and IRS2 and risk of colorectal cancer in the Iranian population? Asian Pac. J. Cancer Prev., 14, 5011-5016.
32. Hughes, L.A.E. et al. (2011) Body size and colorectal cancer risk after 16.3 years of follow-up: an analysis from the Netherlands Cohort Study. Am. J. Epidemiol., 174, 1127-1139.
33. Simons, C.C.J.M. et al. (2013) Physical activity, occupational sitting time, and colorectal cancer risk in the Netherlands cohort study. Am. J. Epidemiol., 177, 514-530.
34. van den Brandt, P.A. et al. (1990) A large-scale prospective cohort study on diet and cancer in The Netherlands. J. Clin. Epidemiol., 43, 285-295.
35. Goldbohm, R.A. et al. (1994) Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur. J. Clin. Nutr., 48, 253-265.
36. Goldbohm, R.A. et al. (1995) Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur. J. Clin. Nutr., 49, 420-429.
37. Cline, R.E. et al. (2003) The fingernails of Mary Sullivan: developing reliable methods for selectively isolating endogenous and exogenous DNA from evidence. J. Forensic Sci., 48, 328-333.
38. van Breda, S.G. et al. (2007) Toenails: an easily accessible and long-term stable source of DNA for genetic analyses in large-scale epidemiological studies. Clin. Chem., 53, 1168-1170.
39. Goldbohm, R.A. et al. (1994) Estimation of the coverage of Dutch municipalities by cancer registries and PALGA based on hospital discharge data. Tijdschr Soc Gezondheidsz, 72, 80-84.
40. Casparie, M. et al. (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell. Oncol., 29, 19-24.
41. World Cancer Research Fund/American Institute for Cancer Research. (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. AICR, Washington DC.
42. Geybels, M.S. et al. (2014) Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer. J. Natl Cancer Inst., 106, dju003.
43. Zhang, J. (2012) Genetic redundancies and their evolutionary maintenance. Adv. Exp. Med. Biol., 751, 279-300.
44. Maher, B. (2008) Personal genomes: the case of the missing heritability. Nature, 456, 18-21.
45. Rosen, C.J. et al. (1998) Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J. Clin. Endocrinol. Metab., 83, 2286-2290.
46. Hughes, L.A. et al. (2009) Self-reported clothing size as a proxy measure for body size. Epidemiology, 20, 673-676.
47. Hettinger, T.H. et al. (1989) Ermittlung des Arbeitsenergieumsatzes bei Dynamisch Muskulaerer Arbeit. Bundesarbeit fuer Arbeitsschutz, Dortmund, Germany.
48. Rothman, K.J. et al. (1998) Modern Epidemiology. Lippincott-Raven Publishers, Philadelphia, PA.
49. Carpenter, J. et al. (2000) Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat. Med., 19, 1141-1164.
50. Barlow, W.E. (1994) Robust variance estimation for the case-cohort design. Biometrics, 50, 1064-1072.
51. Rondini, E.A. et al. (2011) Energy balance modulates colon tumor growth: interactive roles of insulin and estrogen. Mol. Carcinog., 50, 370-382.
52. Pischon, T. et al. (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J. Natl Cancer Inst., 98, 920-931.
53. Grodstein, F. et al. (1999) Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am. J. Med., 106, 574-582.
54. Rothman, K.J. et al. (2005) Causation and causal inference in epidemiology. Am. J. Public Health, 95 (suppl. 1), S144-S150.
55. Aschard, H. et al. (2012) Challenges and opportunities in genome-wide environmental interaction (GWEI) studies. Hum. Genet., 131, 1591-1613.
56. Greenland, S. (1993) Basic problems in interaction assessment. Environ. Health Perspect., 101 (suppl. 4), 59-66.
57. Gilbert-Diamond, D. et al. (2011) Analysis of gene-gene interactions. Curr. Protoc. Hum. Genet., Chapter 1, Unit 1.14. doi:10.1002/0471142905. hg0114s70.
58. Weijenberg, M.P. et al. (2013) The mTOR pathway and the role of energy balance throughout life in colorectal cancer etiology and prognosis: unravelling mechanisms through a multidimensional molecular epidemiologic approach. Curr. Nutr. Rep., 2, 19-26.
59. Pérez-Hernández, A.I. et al. (2014) Mechanisms linking excess adiposity and carcinogenesis promotion. Front. Endocrinol., 5, 65.
60. Simons, C.C.J.M. et al. (2013) A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. Ann. Oncol., 24, 2048-2056.